Temporal trends in heart failure medication prescription in a population-based cohort study.
Alicia UijlIlonca VaartjesS DenaxasHarry HemingwayAnoop ShahJ ClelandDiederick GrobbeeArno HoesFolkert W AsselbergsStefan KoudstaalPublished in: BMJ open (2021)
In the general population, the use of MR-antagonists for HF remained low and did not change throughout 13 years of follow-up. For most patients, few changes were seen in pharmacological management of HF in the 6 months following diagnosis.